Research Studies

We have several ongoing studies at the Anal Cancer Research and Education clinic at UCSF.

Campo R56

Mechanisms of disparities in the natural history of oral and oropharyngeal HPV infection among persons living with HIV.

ANCHOR study

Topical or ablative treatment in preventing anal cancer in patients with HIV and anal high-grade squamous intraepithelial lesions. Closed to accrual. 


A phase 2 evaluation of VGX-3100, a synthetic DNA immunotherapy, targeting human papillomavirus 16 and 18 E6 and E7 proteins, for anal high-grade squamous intraepithelial lesions (HSIL) in HIV-positive individuals.



Contact us to participate in a study